(Q46436094)

English

LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients.

scientific article published on 9 August 2008

Statements

LPIN1 genetic variation is associated with rosiglitazone response in type 2 diabetic patients (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit